Kevin B. Yankton - Apr 10, 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Accounting Officer
Signature
/s/ Alyssa Zhang, Attorney-in-Fact for Kevin B. Yankton
Stock symbol
TWST
Transactions as of
Apr 10, 2023
Transactions value $
-$1,040
Form type
4
Date filed
4/12/2023, 04:00 PM
Previous filing
Apr 4, 2023
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Tax liability -$1.04K -63 -0.68% $16.51 9.19K Apr 10, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F2 Does not include 750 RSUs included in the Reporting Person's last Form 4 which were forfeited upon the reporting person's resignation as an officer, effective May 19, 2023.